The Latest
-
Edwards’ request for broader TAVR Medicare coverage gets pushback
Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but some physicians and rival Medtronic said more data is needed.
-
BD, Waters set completion date for $17.5B biosciences and diagnostics merger
With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
-
FDA guidance eases wearables oversight. But experts have questions about what’s next.
Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.
-
Medtronic targets ASCs with extended Mindray collaboration
Mindray is integrating Medtronic patient monitoring technologies into its platforms to meet the needs of ambulatory surgery centers.
-
Intuitive’s cardiac initiative includes valve repair, LAA closure
With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.
-
Medtronic wins CE mark for single-shot pulsed field ablation catheter
Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.
-
Intuitive pushes into cardiac robotic surgery, ASCs
The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.
-
Congress eyes tackling healthcare consolidation
“I think there’s common ground here,” one Republican congressman said Wednesday during a House Budget Committee hearing. Squaring up against healthcare monopolies would be a major pivot for the GOP.
-
AdvaMed leaders on tariffs, MDUFA and wearables
AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.
-
Integra recalls wound and burn devices amid reports of serious injuries
Packaging failures could lead to breaches in the sterile barrier and patient infections.
-
Abbott posts Q4 sales below expectations
Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.
-
Amazon launches health AI chatbot for One Medical members
The assistant, which can answer health questions and help schedule appointments, comes on the heels of other health-focused AI tools from OpenAI and Anthropic.
-
ECRI names misuse of AI chatbots as top health tech hazard for 2026
The nonprofit said technologies like ChatGPT have suggested incorrect diagnoses, invented body parts and otherwise provided information that could lead to harm.
-
J&J’s cardiovascular business boosts medtech growth in 2025
Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.
-
Retrieved from Anteris Technologies Global on January 21, 2026
Medtronic to buy up to $90M stake in heart valve developer Anteris
Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.
-
BVI appoints Jim Hollingshead as CEO
Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.
-
3 takeaways from Boston Scientific’s $14.5B Penumbra deal
Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.
-
Abbott gets Europe’s CE mark for dual ablation catheter
The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.
-
Boston Scientific recalls stent over issue linked to 3 deaths
The company said the deaths were associated with off-label or investigational use of the device.
-
Intuitive says general surgery, acute care fuel US robot momentum
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.
-
STAAR CEO exits after company rejects Alcon buyout
An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.
-
Boston Scientific to acquire Penumbra for $14.5B
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
-
Deep Dive
5 topics to watch as MDUFA negotiations restart
The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.
-
Trump unveils healthcare affordability plan
The “Great Healthcare Plan” is vague, but would send money directly to ACA enrollees and entrench Trump’s drug pricing deals.
-
Trump issues 25% tariffs on narrow range of semiconductors
The levies, effective Jan. 15, do not cover products used for data centers and consumer applications, per a proclamation signed Wednesday.